Septodont has invested in Balanced Pharma, a U.S.-based company focused on improving dental anesthetics for better patient comfort and safety. This partnership aims to innovate without changing current anesthesia methods, enhancing patient experiences and maintaining high standards in dental care. Septodont, founded in 1932, continues to lead in providing safe, effective dental solutions.
Saint-Maur-des-Fossés, France / 19th December, 2024 / —
Septodont, the leading global manufacturer of local anesthetics in dentistry, is pleased to announce that it has made a strategic investment in U.S.-based Balanced Pharma, a dentist-founded pharmaceutical company with a focus on improved patient comfort and safety.
Balanced Pharma’s drugs currently in development are intended to improve upon current dental anesthetic drugs with elegant design solutions that retain the standard cartridge, safety & efficacy profile and shelf-life.
This investment underscores Septodont’s commitment to accelerating innovation and delivering benefits to patients and dentists without changing the means of administering anesthesia.
As a recognized authority in dental anesthesia, Septodont is uniquely positioned to partner with Balanced Pharma and help dental practices to deliver superior patient experiences.
Founded in 1932, Septodont aims to enhance lives by providing safe and effective healthcare solutions and to provide its customers with dental products and services that are unsurpassed in meeting their expectations for quality and performance. The global healthcare solutions provider, which currently holds the largest market share in local dental anesthetics, consistently pursues innovation as it looks to provide dentists with more tools to enhance the patient comfort.
Sign up now and get an exclusive access to: